<DOC>
	<DOCNO>NCT01752894</DOCNO>
	<brief_summary>The purpose study 1 &gt; compare neointimal stent coverage OCT-guided vs. Angio-guided PCI , 2 &gt; compare neointimal stent coverage 3 month EES vs BES implantation , 3 &gt; determine duration dual antiplatelet therapy OCT measurement 3 month</brief_summary>
	<brief_title>DETErmination Duration Dual Antiplatelet Therapy Degree Coverage The Struts Optical Coherence Tomography From Randomized Comparison Between Everolimus-eluting Stents ( EES ) Versus Biolimus A9-eluting Stents ( BES )</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Patients ≥ 20 year old Patients ischemic heart disease consider coronary revascularization stent implantation . Significant coronary de novo lesion ( stenosis &gt; 70 % quantitative angiographic analysis ) treat single DES ≤ 25mm Reference vessel diameter 2.5 3.5 mm operator assessment Complex lesion morphology arotaostial , unprotected leave main , chronic total occlusion , graft , thrombosis , restenosis Reference vessel diameter &lt; 2.5 mm &gt; 4.0mm Heavy calcify lesion ( definite calcify lesion angiogram ) Primary PCI STEMI Contraindication antiplatelet agent Treated DES within 3 month vessel Creatinine level ≥ 2.0 mg/dL ESRD Severe hepatic dysfunction ( 3 time normal reference value ) Pregnant woman woman potential childbearing Life expectancy &lt; 1 year</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>